Abstract
Progress in the treatment of rheumatic diseases is associated with the use of drugs focused on modifying disease mechanisms, which in turn leads to a significant improvement in health. Modern treatment is also associated with reducing the risk of disability and exclusion from important social roles. New drugs, including biological drugs, are expensive and require compliance with the regime related to their use. The above-mentioned factors make it necessary to change attitudes and to strengthen the patient’s motivation to comply with medical recommendations. The paper presents a terminological base in the field of compliance, adherence, concordance and persistence. Moreover, factors limiting compliance with recommendations in the case of chronic diseases were indicated, as well as methods of measuring compliance and adherence, both objective and subjective. It was also shown that the pandemic situation significantly reduced the readiness of patients to comply with therapeutic recommendations, which requires a redefinition of the model of cooperation between the doctor and the patient, and numerous methods of facilitating adherence have been proposed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
